ClinicalStudyDataRequest.com.Com Expansion Enables Researchers To Now Access Patient-Level Data In More Than 3,000 Clinical Trials

BOSTON--(BUSINESS WIRE)--ClinicalStudyDataRequest.com (CSDR), a cross-industry initiative providing researchers with access to clinical trial data from 13 major pharmaceutical companies, including trials that involve multiple sponsors, has significantly increased the number of trials available to more than 3,200.

CSDR offers medical and scientific researchers an unparalleled array of clinical trial data that can facilitate collaboration, advance scientific knowledge, and potentially improve outcomes for patients. Through this portal, researchers can request anonymized patient-level data from a list of more than 3,200 clinical trials via an independently reviewed process managed by the Wellcome Trust.

The available trials span all major disease areas. For example, there are more than 300 diabetes trials listed. Since the initiative was launched, there have been more than 250 requests from researchers for trial data. Study sponsors interested in listing studies on the site may contact CSDR here.

“ClinicalStudyDataRequest.com and its member companies are proud to have reached these important milestones of more than 3,200 trials listed and 250 requests made. This consortium continues to raise the goal and sponsors are working together and with others to continually seek new ways to increase the number of trials listed and take steps to facilitate easier request and data-access mechanisms,” said Scott Martin, chair of the ClinicalStudyDataRequest.com Steering Committee.

About ClinicalStudyDataRequest.com

ClinicalStudyDataRequest.com is the industry leader in global clinical trial data transparency. Its multi-sponsor Request System provides a secure process for researchers to request access to global clinical trial data through a publicly available website. An Independent Review Panel and process overseen by the Wellcome Trust review data requests received from external researchers. Access to clinical trial data provides opportunities to conduct further research that can help advance medical science and improve patient care. This helps ensure the data provided by research participants are used to maximum effect in the creation of knowledge and understanding.

About ideaPoint

ClinicalStudyDataRequest.com is built on a unique platform created by ideaPoint, which is dedicated to providing clients with software solutions that help them repeatedly spot and seize the innovation and partnering opportunities that create growth through new products, new services and new business models. Since its launch in 2008, ideaPoint has delivered the software to transform and solidify innovation and strategic growth programs across global companies in science-based industries. For additional information, please visit http://idea-point.com.